Halobetasol Propionate
NDC 21922-108, Halobetasol Propionate, ointment, from Encube Ethicals, Inc..
- Product NDC
- 21922-108
- Status
- Listed
- Labeler
- Encube Ethicals, Inc.
- Dosage form
- OINTMENT
- Route
- TOPICAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA209978
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/21922-108 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- HALOBETASOL PROPIONATE.5 mg/g
Pharmacologic classes
Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 21922-108-04 | 21922010804 | 1 TUBE in 1 CARTON (21922-108-04) / 15 g in 1 TUBE |
| 21922-108-14 | 21922010814 | 1 TUBE in 1 CARTON (21922-108-14) / 50 g in 1 TUBE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/d4f03a79-3d5e-4a39-8ab0-8ebd3d804e39
Use it
Look up 21922-108 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/21922-108 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 21922-108. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.